It happens in doctors' offices everywhere. A patient says, "I can't sleep." The doctor reaches for a prescription pad and writes down a drug called quetiapine. Quick fix, problem solved. Right?

Not so fast.

Quetiapine was actually invented to treat serious mental health conditions like schizophrenia and bipolar disorder. But somewhere along the way, it became one of America's go-to sleep aids, with 10.7 million prescriptions in 2023 alone. Most of those were for sleep, a use it was never approved for. Now a new study is waving a red flag, especially for one group of people who overlap heavily with poor sleepers.

The study in plain English

Researchers in Australia ran a careful experiment with 15 adults who had a breathing problem during sleep called obstructive sleep apnea (where the airway keeps collapsing and breathing repeatedly stops and starts). These folks also had trouble staying asleep, a super common complaint.

Each person spent two nights in a sleep lab. One night they got a low dose of quetiapine (50 mg). The other night they got a fake pill (a placebo). Nobody knew which was which until the end. Then scientists measured how they slept and how sharp they were the next morning.

Good night, rough morning

At first, the results looked great.

On quetiapine, people actually breathed better during sleep. Their apnea events dropped from 27 to 20 per hour. They woke up less often. Their sleep efficiency climbed from 80 to 87 percent. They even kept their oxygen levels steady. So they slept more smoothly and breathed better. Sounds like a win.

Then morning arrived and ruined the party.

On a test of alertness, reaction times were clearly slower after quetiapine. On a 30-minute driving simulator, their steering wandered way more than on the placebo night. These weren't tiny lab quirks. They're exactly the kind of slips that cause real-world accidents, the morning after, when most people are, you know, driving to work.

So the trade was a better night's sleep for a foggier, more dangerous morning.

A popular drug with a thin résumé

Here's the awkward part. For all those millions of prescriptions, the evidence that quetiapine even helps sleep is shockingly thin.

As of 2014, its use for plain insomnia (in people without a mental health condition) had been tested in just two studies covering a grand total of 31 patients. No study had ever compared it head-to-head with an actual approved sleep medicine. A later review of 21 trials did find it improved sleep quality and added about 48 minutes of sleep, but it also caused frequent side effects, and it didn't beat other options.

And the side effects aren't minor. Even at low doses, quetiapine can cause weight gain, blood sugar and cholesterol problems, daytime grogginess, dizziness when standing, and, rarely, lasting movement problems. The official drug label even warns people to be careful about driving. In one set of trials, more than half the patients reported daytime sleepiness.

Official guidelines for treating long-term insomnia flat-out advise against using drugs like quetiapine for sleep, noting the evidence is weak and the risks are real, including a higher risk of death in elderly patients with dementia.

The hidden danger: sleep apnea nobody noticed

Now here's the scariest piece. Many people who get prescribed quetiapine for sleep may secretly have sleep apnea, and nobody checked.

Insomnia and sleep apnea are best friends who hang out together way more than people realize. Roughly 35 percent of insomnia patients also have sleep apnea. Going the other way, many sleep apnea patients have insomnia too, and up to 80 percent report at least one insomnia symptom, most often trouble staying asleep, which is the very thing that lands them on quetiapine in the first place.

See the trap? A patient can't stay asleep. The doctor prescribes quetiapine without testing for apnea. The patient does sleep more solidly, but the apnea stays hidden and untreated, while the sedating pill makes the next day blurry and may even hide the daytime sleepiness that would've tipped off the doctor.

This isn't just a theory. In some patients, sedating drugs like quetiapine actually worsened breathing during sleep, separate from any weight gain. There are even reports of people landing in serious respiratory trouble after a single dose, because their undiagnosed apnea got worse.

⚠️ If you take quetiapine for sleep, don't drive the next morning until you know how it affects you — and get screened for sleep apnea before staying on it long-term.

In the controlled lab study, driving simulator steering wandered substantially more the morning after a single 50 mg dose. These weren't subtle effects — they're the kind that cause real accidents. If you're a new prescription, expect next-day grogginess and arrange transport accordingly until you've calibrated. Beyond the immediate driving risk, the bigger trap is undiagnosed sleep apnea: roughly 35% of insomnia patients have it, and sedatives like quetiapine can worsen breathing events while masking the daytime sleepiness that would've tipped off the doctor. Ask for a sleep study before committing to long-term use. And never stop quetiapine abruptly — if you were prescribed it for a psychiatric condition (not insomnia), withdrawal can be serious; the conversation about switching is with your prescriber.

What works better

The good news is there's a clearly better first step, and it isn't a pill at all. It's a type of talk-based therapy called CBT-I (cognitive behavioral therapy for insomnia). Every major guideline recommends it as the first-line treatment. It teaches your brain and body to sleep better, and the effects tend to last.

When medication is needed, there are sleep drugs that are actually approved and studied for insomnia. And for people who have both insomnia and sleep apnea, combining CBT-I with a breathing-support device (like a CPAP machine) tends to beat treating just one problem alone.

The bottom line

Yes, the new study is small, just 15 people, and the findings need confirming in bigger trials. But the message fits a much larger pile of evidence: quetiapine shouldn't be the routine answer for sleep problems, especially in anyone who might have sleep apnea. The modest overnight gains simply aren't worth the foggy, risky mornings.

The deeper issue is bigger than one drug. When 10.7 million prescriptions go out each year for a medicine that was never approved for sleep, barely tested for it, and carries real risks, while the proven first-line treatment goes underused, something in the system is off.

The real alarm bells aren't only about quetiapine. They're about screening for sleep apnea before reaching for a sedative, making proven treatments easier to get, and closing the gap between what the science says and what actually gets prescribed.

This article is for general education and isn't medical advice. Quetiapine has legitimate uses for psychiatric conditions like schizophrenia and bipolar disorder — and never stop a psychiatric medication abruptly without a prescriber's plan, because withdrawal can be serious and rebound symptoms can be dangerous. If you were prescribed quetiapine specifically for sleep and you don't have a psychiatric condition, that's a conversation about switching to a guideline-recommended option (CBT-I as first-line; approved sleep medications when needed). And if you have insomnia that includes trouble staying asleep, snoring, or daytime fatigue, ask for a sleep study before any sedative — undiagnosed sleep apnea is the most-missed diagnosis in chronic insomnia.